- Telehealth Visits
- Insurance plan information
Melanie C. Majure, MD
Breast Medical Oncology- Telehealth Visits
- Insurance plan information
Melanie C. Majure, MD
Breast Medical Oncology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Medical Oncology, American Board of Internal Med/Medical Oncology
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Hematology - Oncology, University of CA at San Francisco - Pathology GME
Residency
- Internal Medicine, Stanford University Medical Center-GME
Internship
- Internal Medicine, Stanford University Medical Center-GME
Degree
- MD, Stanford University School of Medicine
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%222056%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222056%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 87 reviews
- December 8, 20255 out of 5 Stars
I would whole heartly recommend the doctor to family and friends.
- December 3, 20255 out of 5 Stars
Dr. Majure is an excellent and thoughtful clinician. Always informed and attentive with compassion.
- November 20, 20255 out of 5 Stars
Dr. Majure is fantastic!
- November 14, 20255 out of 5 Stars
Dr. Majure is very thorough and caring and kind. She comes into the appointment aware of my issues and shows genuine concern.
- November 10, 20255 out of 5 Stars
Dr Majure is wonderful!
- November 3, 20255 out of 5 Stars
Dr Majure is always concerned, caring and gives the best advice any patient can hope for.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.